Two young sci­en­tists bag $20M to per­fect their CRISPR at­tack on dis­ease-caus­ing bac­te­ria at up­start Eli­go

What if you could find a way to de­liv­er new tech­nol­o­gy like CRISPR in­to the teem­ing mi­cro­bio­me re­gions in­side the hu­man body, de­liv­er­ing in­struc­tions to slice in­to spe­cif­ic strains of trou­ble­some bac­te­ria. Your de­liv­ery ves­sels made of bits of DNA and pro­teins would have to sur­vive an acid washed storm in the stom­ach and then ap­pear where need­ed for an at­tack on a spe­cif­ic tar­get — such as a rare dis­ease trig­gered by bac­te­ria.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.